Korea's DNA Link Orders 10 Protons to Expand Clinical Sequencing Services | GenomeWeb

Korean sequencing service provider DNA Link has ordered 10 Life Technologies' Ion Proton systems, which it will use to expand its clinical sequencing offerings, especially in the area of cancer.

DNA Link CEO Jong Eun Lee said the company plans to initially use the machines for exome and transcriptome sequencing of cancer samples for research purposes, and plans to develop diagnostic gene panels within the next year.

Additionally, he said the company would seek accreditation that is comparable to CLIA.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.